NewsBenzingaActinium Pharma To Present Preclinical Data Supporting ATNM-400's Broad Potential At 39th Annual Congress Of EANM Actinium Pharma To Present Preclinical Data Supporting ATNM-400's Broad Potential At 39th Annual Congress Of EANM Benzinga 2026.10.16 12:37 (GMT+0) Open on Benzinga Other news Barclays Maintains Overweight on Charles Schwab, Lowers Price Target to $115 Barclays Maintains Overweight on Taiwan Semiconductor, Raises Price Target to $670 Barclays Maintains Overweight on Post Holdings, Lowers Price Target to $88 Barclays Maintains Overweight on Oatly Group, Lowers Price Target to $13 Barclays Maintains Equal-Weight on Mosaic, Lowers Price Target to $22 Barclays Maintains Overweight on Mondelez International, Raises Price Target to $72
